EPVACTIN

Marca svizra · 464032 · Marca da pled · Stizzada

Inscripziun en il register

Numer da registraziun
464032
Numer da la dumonda
02702/1999
Status
Stizzada
Tip
Marca da pled
Deponida
26-03-1999
Registrada
16-08-1999
Publitgada
13-09-1999
Stizzada
02-11-2009
Motiv
Betg prolungada
Prioritad
29.09.1998 GB
Remartgas
Detaillierte Liste im Aktenheft.
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Impfstoffe für die Behandlung und/oder Prävention von Hepatitis.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 02-11-2009

    Stritgà, betg prolungà

    Published in Swissreg on 02.11.2009

  2. 05-05-2008

    Adressa dal represchentant midada

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel → BOHEST AG, Postfach 160, 4003 Basel

    Published in the SOGC no. 85 of 05.05.2008

  3. 12-05-2003

    Adressa dal possessur midada

    Owner
    SmithKline Beecham Biologicals, Manufacturing S.A., Rue de l'Institut 89, 1330 Rixensart, Belgium → GlaxoSmithKline Biologicals Manufacturing S.A., Rue de l'Institut 89, 1330 Rixensart, Belgium

    Published in the SOGC no. 89 of 12.05.2003

  4. 23-11-1999

    Priorities

    Priorities
    29.09.1999 GB → 29.09.1998 GB

    Published in the SOGC no. 228 of 23.11.1999

  5. 13-09-1999

    Registrà

    Published in the SOGC no. 177 of 13.09.1999

Partidas

Possessura

GlaxoSmithKline Biologicals Manufacturing S.A.

Rue de l'Institut 89, 1330 Rixensart, BE

Represententa

BOHEST AG

Postfach 160, 4003 Basel

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.